Biliary Atresia Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: B044A98E4499EN
Market Monitor Global

Abstracts

Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.

This report contains market size and forecasts of Biliary Atresia Treatment in Global, including the following market information:

Global Biliary Atresia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Biliary Atresia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drug Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biliary Atresia Treatment include AstraZeneca, Daiichi Sankyo, Eisai, Johnson & Johnson, Novartis and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biliary Atresia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biliary Atresia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Biliary Atresia Treatment Market Segment Percentages, by Type, 2021 (%)

• Drug Treatment
• Surgery Treatment

Global Biliary Atresia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Biliary Atresia Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Biliary Atresia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Biliary Atresia Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biliary Atresia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Biliary Atresia Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Daiichi Sankyo
• Eisai
• Johnson & Johnson
• Novartis
• Pfizer

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Biliary Atresia Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Biliary Atresia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BILIARY ATRESIA TREATMENT OVERALL MARKET SIZE

2.1 Global Biliary Atresia Treatment Market Size: 2021 VS 2028
2.2 Global Biliary Atresia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Biliary Atresia Treatment Players in Global Market
3.2 Top Global Biliary Atresia Treatment Companies Ranked by Revenue
3.3 Global Biliary Atresia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Biliary Atresia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biliary Atresia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biliary Atresia Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Biliary Atresia Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Biliary Atresia Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Biliary Atresia Treatment Market Size Markets, 2021 & 2028
  4.1.2 Drug Treatment
  4.1.3 Surgery Treatment
4.2 By Type - Global Biliary Atresia Treatment Revenue & Forecasts
  4.2.1 By Type - Global Biliary Atresia Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Biliary Atresia Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Biliary Atresia Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Biliary Atresia Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Biliary Atresia Treatment Revenue & Forecasts
  5.2.1 By Application - Global Biliary Atresia Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Biliary Atresia Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Biliary Atresia Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Biliary Atresia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Biliary Atresia Treatment Revenue & Forecasts
  6.2.1 By Region - Global Biliary Atresia Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Biliary Atresia Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Biliary Atresia Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Biliary Atresia Treatment Revenue, 2017-2028
  6.3.2 US Biliary Atresia Treatment Market Size, 2017-2028
  6.3.3 Canada Biliary Atresia Treatment Market Size, 2017-2028
  6.3.4 Mexico Biliary Atresia Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Biliary Atresia Treatment Revenue, 2017-2028
  6.4.2 Germany Biliary Atresia Treatment Market Size, 2017-2028
  6.4.3 France Biliary Atresia Treatment Market Size, 2017-2028
  6.4.4 U.K. Biliary Atresia Treatment Market Size, 2017-2028
  6.4.5 Italy Biliary Atresia Treatment Market Size, 2017-2028
  6.4.6 Russia Biliary Atresia Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Biliary Atresia Treatment Market Size, 2017-2028
  6.4.8 Benelux Biliary Atresia Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Biliary Atresia Treatment Revenue, 2017-2028
  6.5.2 China Biliary Atresia Treatment Market Size, 2017-2028
  6.5.3 Japan Biliary Atresia Treatment Market Size, 2017-2028
  6.5.4 South Korea Biliary Atresia Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Biliary Atresia Treatment Market Size, 2017-2028
  6.5.6 India Biliary Atresia Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Biliary Atresia Treatment Revenue, 2017-2028
  6.6.2 Brazil Biliary Atresia Treatment Market Size, 2017-2028
  6.6.3 Argentina Biliary Atresia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Biliary Atresia Treatment Revenue, 2017-2028
  6.7.2 Turkey Biliary Atresia Treatment Market Size, 2017-2028
  6.7.3 Israel Biliary Atresia Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Biliary Atresia Treatment Market Size, 2017-2028
  6.7.5 UAE Biliary Atresia Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Biliary Atresia Treatment Major Product Offerings
  7.1.4 AstraZeneca Biliary Atresia Treatment Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Daiichi Sankyo
  7.2.1 Daiichi Sankyo Corporate Summary
  7.2.2 Daiichi Sankyo Business Overview
  7.2.3 Daiichi Sankyo Biliary Atresia Treatment Major Product Offerings
  7.2.4 Daiichi Sankyo Biliary Atresia Treatment Revenue in Global Market (2017-2022)
  7.2.5 Daiichi Sankyo Key News
7.3 Eisai
  7.3.1 Eisai Corporate Summary
  7.3.2 Eisai Business Overview
  7.3.3 Eisai Biliary Atresia Treatment Major Product Offerings
  7.3.4 Eisai Biliary Atresia Treatment Revenue in Global Market (2017-2022)
  7.3.5 Eisai Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Biliary Atresia Treatment Major Product Offerings
  7.4.4 Johnson & Johnson Biliary Atresia Treatment Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Biliary Atresia Treatment Major Product Offerings
  7.5.4 Novartis Biliary Atresia Treatment Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Biliary Atresia Treatment Major Product Offerings
  7.6.4 Pfizer Biliary Atresia Treatment Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Biliary Atresia Treatment Market Opportunities & Trends in Global Market
Table 2. Biliary Atresia Treatment Market Drivers in Global Market
Table 3. Biliary Atresia Treatment Market Restraints in Global Market
Table 4. Key Players of Biliary Atresia Treatment in Global Market
Table 5. Top Biliary Atresia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biliary Atresia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biliary Atresia Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biliary Atresia Treatment Product Type
Table 9. List of Global Tier 1 Biliary Atresia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biliary Atresia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Biliary Atresia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biliary Atresia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biliary Atresia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Biliary Atresia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biliary Atresia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biliary Atresia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Biliary Atresia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biliary Atresia Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biliary Atresia Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biliary Atresia Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biliary Atresia Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biliary Atresia Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biliary Atresia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biliary Atresia Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Biliary Atresia Treatment Product Offerings
Table 32. AstraZeneca Biliary Atresia Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Daiichi Sankyo Corporate Summary
Table 34. Daiichi Sankyo Biliary Atresia Treatment Product Offerings
Table 35. Daiichi Sankyo Biliary Atresia Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Eisai Corporate Summary
Table 37. Eisai Biliary Atresia Treatment Product Offerings
Table 38. Eisai Biliary Atresia Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Biliary Atresia Treatment Product Offerings
Table 41. Johnson & Johnson Biliary Atresia Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Biliary Atresia Treatment Product Offerings
Table 44. Novartis Biliary Atresia Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Biliary Atresia Treatment Product Offerings
Table 47. Pfizer Biliary Atresia Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Biliary Atresia Treatment Segment by Type in 2021
Figure 2. Biliary Atresia Treatment Segment by Application in 2021
Figure 3. Global Biliary Atresia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biliary Atresia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biliary Atresia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biliary Atresia Treatment Revenue in 2021
Figure 8. By Type - Global Biliary Atresia Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biliary Atresia Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biliary Atresia Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biliary Atresia Treatment Revenue Market Share, 2017-2028
Figure 12. US Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biliary Atresia Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biliary Atresia Treatment Revenue Market Share, 2017-2028
Figure 24. China Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biliary Atresia Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biliary Atresia Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biliary Atresia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Biliary Atresia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Daiichi Sankyo Biliary Atresia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eisai Biliary Atresia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Biliary Atresia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Biliary Atresia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Biliary Atresia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)